Esketamine 0.3mg/kg
Esketamine 0.3mg/kg is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy
Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression
Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression
Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion
Clinical Trials (5)
The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy
Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression
Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression
Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5